Department of Otorhinolaryngology - Head and Neck Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Division of Otolaryngology-Head and Neck Surgery, NorthShore University Health System, The University of Chicago, Pritzker School of Medicine, Evanston, Illinois, USA.
World Neurosurg. 2022 Nov;167:e664-e669. doi: 10.1016/j.wneu.2022.08.064. Epub 2022 Aug 24.
Rathke cleft cysts (RCCs) arise from the development of the Rathke pouch. Recurrence is common after either drainage or cyst removal. The endoscopic endonasal approach (EEA) is increasingly utilized for the management of RCC. Various techniques have been described to try to reduce the rates of recurrence. We studied the effect of fenestration with a nasoseptal flap (NSF) on recurrence rates by comparing a cohort of patients undergoing this technique to a cohort of patients undergoing conventional drainage.
Patients who underwent EEA for RCC between 2011 and 2020 were identified and divided into 2 cohorts: conventional fenestration versus fenestration with NSF. Surgical approach, reconstructive method, and recurrences were recorded. Primary end point was symptomatic or radiographic recurrence.
21 patients were identified undergoing EEA. An NSF was used to line the cyst cavity in 11 cases. Conventional fenestration without mucosal reconstruction was performed in the remaining 10 cases. In the cases without NSF, 5 (50%) developed recurrence requiring revision surgery, while there was only one recurrence in the NSF group (P < 0.05). In patients requiring revision, all had an NSF placed and none had a second recurrence of their RCC.
NSF placement into a fenestrated RCC is useful to prevent cyst reaccumulation and reoperation. Typical fenestration carries an unacceptably high rate of recurrence.
Rathke 裂隙囊肿(RCC)起源于 Rathke 囊的发育。无论是引流还是囊肿切除后,复发都很常见。经鼻内镜(EEA)入路越来越多地用于 RCC 的治疗。为了降低复发率,已经描述了各种技术。我们通过比较接受这种技术的患者队列和接受常规引流的患者队列,研究了用鼻中隔瓣(NSF)开窗对复发率的影响。
确定了 2011 年至 2020 年间接受 EEA 治疗的 RCC 患者,并将其分为两组:常规开窗与 NSF 开窗。记录手术入路、重建方法和复发情况。主要终点是症状性或影像学复发。
确定了 21 例接受 EEA 的患者。11 例使用 NSF 衬里囊肿腔。其余 10 例未行黏膜重建的常规开窗。在未使用 NSF 的病例中,有 5 例(50%)发生了需要再次手术的复发,而 NSF 组只有 1 例复发(P < 0.05)。在需要再次手术的患者中,所有患者均放置了 NSF,且无一人再次发生 RCC 复发。
NSF 置入到开窗的 RCC 中有助于防止囊肿再次积聚和再次手术。典型的开窗术有很高的复发率。